Combination therapy options for type 2 diabetes

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 94卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [1] Rationale and options for combination therapy in the treatment of Type 2 diabetes
    L. Van Gaal
    I. De Leeuw
    Diabetologia, 2003, 46 : M44 - M50
  • [2] Options for empagliflozin in combination therapy in type 2 diabetes mellitus
    Hershon, Kenneth S.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 155 - 172
  • [3] Rationale and options for combination therapy in the treatment of Type 2 diabetes
    Van Gaal, LF
    De Leeuw, IH
    DIABETOLOGIA, 2003, 46 (Suppl 1) : M44 - M50
  • [4] Combination therapy for type 2 diabetes
    Bell, DSH
    AMERICAN FAMILY PHYSICIAN, 2001, 64 (11) : 1812 - +
  • [5] Repaglinide in combination therapy in type 2 diabetes
    Moses, R
    DIABETES & METABOLISM, 1999, 25 : 26 - 27
  • [6] Initial Combination Therapy in Type 2 Diabetes
    Kim, Ji Yoon
    Kim, Nam Hoon
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 23 - 32
  • [7] Oral combination therapy for type 2 diabetes
    Charpentier, G
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 : S70 - S76
  • [8] An alternative combination therapy for type 2 diabetes?
    Ostoft, Signe H.
    Christensen, Mikkel
    LANCET, 2015, 385 (9982): : 2020 - 2022
  • [9] Rational combination therapy for type 2 diabetes
    Del Prato, Stefano
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (05): : 328 - 329
  • [10] Combination Lipid Therapy in Type 2 Diabetes
    Michael Clearfield
    Current Atherosclerosis Reports, 2011, 13 (1) : 1 - 3
12345